Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial.
Acta Haematol
; 141(2): 111-118, 2019.
Article
in En
| MEDLINE
| ID: mdl-30726834
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dexamethasone
/
Antineoplastic Combined Chemotherapy Protocols
/
Cyclophosphamide
/
Bortezomib
/
Multiple Myeloma
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Guideline
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Acta Haematol
Year:
2019
Type:
Article
Affiliation country:
Japan